HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter L A Giesen Selected Research

von Willebrand Diseases (von Willebrand's Disease)

1/2003Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucocutaneous haemorrhages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter L A Giesen Research Topics

Disease

4Thrombosis (Thrombus)
06/2018 - 01/2004
2Hemorrhage
08/2006 - 01/2003
2Hemophilia A (Haemophilia)
08/2006 - 05/2003
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2023
1Gray Platelet Syndrome
10/2023
1Stroke (Strokes)
06/2005
1Cardiovascular Diseases (Cardiovascular Disease)
09/2004
1von Willebrand Diseases (von Willebrand's Disease)
01/2003

Drug/Important Bio-Agent (IBA)

4ThrombinFDA Link
10/2023 - 01/2003
3AnticoagulantsIBA
01/2005 - 05/2003
2Clopidogrel (Plavix)FDA Link
10/2023 - 06/2005
1Adenosine Diphosphate (ADP)IBA
10/2023
1vasodilator-stimulated phosphoproteinIBA
10/2023
1TicagrelorIBA
10/2023
1ColchicineFDA LinkGeneric
10/2023
1Prasugrel HydrochlorideFDA Link
10/2023
1Thromboplastin (Tissue Factor)IBA
06/2018
1Serine Proteases (Serine Protease)IBA
08/2006
1Factor VIIIaIBA
08/2006
1thrombin receptor peptide (42-47)IBA
06/2005
1PhosphatidylserinesIBA
06/2005
1Fish OilsIBA
09/2004
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
09/2004
1CollagenIBA
01/2004
1Phospholipids (Phosphatides)FDA LinkGeneric
05/2003
1Oral ContraceptivesIBA
05/2003

Therapy/Procedure

1Blood Component Removal (Apheresis)
01/2004